Today: 9 June 2026
Lockheed Martin stock jumps after hypersonic missile engine test with GE, Stinger-replacement flight milestone

Lockheed Martin stock jumps after hypersonic missile engine test with GE, Stinger-replacement flight milestone

NEW YORK, Jan 14, 2026, 19:15 ET — After-hours

  • Lockheed Martin shares climbed 2.6% in late trading amid widespread gains across U.S. defense stocks
  • Lockheed and GE Aerospace announced successful tests of a new ramjet design targeting hypersonic missile applications
  • Citi raised its price target for Lockheed to $592 ahead of the Jan. 29 earnings call

Lockheed Martin shares jumped 2.6% in after-hours trading Wednesday following news that the defense giant and GE Aerospace wrapped up engine tests for a new ramjet designed for hypersonic missiles. Northrop Grumman climbed 4.4%, RTX edged up 2.4%, and General Dynamics gained 0.7%. GE Aerospace, however, slipped 2.5%.

This update is crucial as investors seek clear signs that U.S. weapons makers are accelerating progress on next-gen missile technology and expanding the supply chains needed to support it. Hypersonic programs come with high costs and complexity, but any breakthrough news can quickly sway sentiment in a sector where contract timelines stretch over years.

The Pentagon’s move to pump $1 billion into L3Harris Technologies’ rocket motor division has sharpened that focus. This rare direct investment aims to secure propulsion for weapons like Tomahawks and Patriot interceptors. Officials described it as a shift toward backing critical suppliers outright. Separately, the department struck a seven-year deal with Lockheed last week to boost PAC-3 missile production from around 600 to 2,000 units annually.

Lockheed and GE have conducted a series of tests proving the viability of a liquid-fueled “rotating detonation” ramjet — an air-breathing engine that uses detonation waves instead of conventional combustion to burn fuel — designed for missiles capable of hypersonic speeds, exceeding five times the speed of sound. GE’s Mark Rettig said the tests “exceeded expectations,” while Lockheed’s Randy Crites emphasized their goal of delivering “affordable capability” with “extended range at extreme speeds.” Media – Lockheed Martin

Lockheed announced it wrapped up the first flight test of its Next-Generation Short-Range Interceptor the day before, aiming to replace the Stinger missile. Conducted at White Sands Missile Range, the test confirmed the system’s performance and advanced critical subsystems. The design features an “open systems architecture,” allowing hardware and software updates via a plug-and-play setup. “Our team’s shared mission, innovative approach and agility were essential,” said Crites. Chris Murphy, the business development lead, added the controlled flight test series was completed “in less than six months.” Media – Lockheed Martin

Citi’s John Godyn bumped his price target for Lockheed up to $592 from $505, maintaining a Neutral rating. He noted that “the sector’s momentum is likely to continue through the first half of 2026.” Remember, a price target reflects where an analyst thinks the stock might trade over the next year, not a promise. TipRanks

Yet the short-term wager isn’t without its usual pitfalls: hypersonic propulsion development can hit snags in both engineering and test ranges. The Stinger-replacement program remains in early flight testing, with no production green light yet. Any delays or cost overruns could quickly shift contractor sentiment, particularly as Washington steps up its scrutiny of industrial execution.

Lockheed plans to release its fourth-quarter and full-year 2025 results before the market opens on Jan. 29. The earnings call, featuring CEO Jim Taiclet and CFO Evan Scott, is scheduled for 8:30 a.m. ET.

Traders will be watching to see if Wednesday’s gains stick through Thursday. Attention also turns to Lockheed for any fresh test updates or new details on contracts ahead of the Jan. 29 call.

Stock Market Today

  • Sensex Gains 394 Points as RBI Forex Measures and Lower Crude Oil Prices Boost Market
    June 9, 2026, 8:50 AM EDT. On June 9, 2026, Indian markets rebounded strongly with Sensex climbing 394 points to 73,918 and Nifty rising 119 points to 23,242. The Nifty Bank index surged 1,130 points led by gains in PSU and private banks. The recovery followed a drop in Brent crude oil below $94 per barrel and the Reserve Bank of India's new forex policies, including concessional FCNR(B) deposits and ECB swap facilities aimed at attracting foreign currency inflows. The government's introduction of a ₹10,000 crore Aviation Turbine Fuel price stabilization fund and uniform ATF pricing bolstered airline stocks, notably InterGlobe Aviation rising nearly 4%. PSU Banks led sector gains while IT stocks lagged. Positive global cues further supported broad buying on Dalal Street for a robust market turnaround.

Latest articles

AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Grab Stock Barely Moves As Taiwan Push And Singapore Merchant Plan Put Growth Back In Focus

Grab Stock Barely Moves As Taiwan Push And Singapore Merchant Plan Put Growth Back In Focus

9 June 2026
Grab shares hovered near $3.33 in pre-market trading after unveiling a new Singapore merchant programme and Taiwan partner commitments, as investors weigh growth initiatives against regulatory hurdles and consumer spending pressure; the stock’s muted move reflects ongoing uncertainty around its proposed foodpanda Taiwan acquisition and potential margin impacts from promotions.
Morgan Stanley stock slips before earnings as Wall Street digests big-bank signals
Previous Story

Morgan Stanley stock slips before earnings as Wall Street digests big-bank signals

NASA pulls Crew-11 from ISS in first medical evacuation as SpaceX Dragon heads for splashdown
Next Story

NASA pulls Crew-11 from ISS in first medical evacuation as SpaceX Dragon heads for splashdown

Go toTop